JG
AGIO icon

Joel Greenblatt’s Agios Pharmaceuticals AGIO Stock Holding History

Joel Greenblatt’s Portfolio AGIO Stock Details AGIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-4,851
Closed -$327K – 1122
2019
Q1 		$327K Buy
+4,851
New +$283K ﹤0.01% 969
2015
Q3 		– Sell
-10,967
Closed -$1.22M – 898
2015
Q2 		$1.22M Buy
+10,967
New +$1.18M 0.01% 602

Other funds holding AGIO

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.75B AUM 68.58% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Joel Greenblatt's AGIO Position: Q2 2019 in Review

Joel Greenblatt sold out of Agios Pharmaceuticals (AGIO) in Q2 2019, closing a stake of 4,851 shares — an estimated $327K sold.

Joel Greenblatt first reported a position in AGIO in Q2 2015 and held it in 2 quarters. The position peaked at $1.22M in Q2 2015. 189 funds tracked by Wall St. Rank hold AGIO as of Q2 2019.

  • Joel Greenblatt reported no remaining Agios Pharmaceuticals position as of Q2 2019 after selling out during the quarter.
  • Joel Greenblatt sold 4,851 Agios Pharmaceuticals shares in Q2 2019, an estimated $327K.
  • Joel Greenblatt first reported a position in Agios Pharmaceuticals in Q2 2015 and held it in 2 quarters.
  • Joel Greenblatt's Agios Pharmaceuticals position peaked at $1.22M in Q2 2015.
  • 189 funds tracked by Wall St. Rank held Agios Pharmaceuticals as of Q2 2019.

Based on Gotham Asset Management's 13F filing for Q2 2019, filed 14 Aug 2019.